Christopher Brett Primiano is Chief Business Officer of Aura Biosciences, Inc.. Currently has a direct ownership of 8,750 shares of AURA, which is worth approximately $68,075. The most recent transaction as insider was on Oct 28, 2021, when has been sold 8,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.75K
0% 3M change
0% 12M change
Total Value Held $68,075

Christopher Brett Primiano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 28 2021
BUY
Grant, award, or other acquisition
-
8,750 Added 50.0%
8,750 Common Stock

Also insider at

KPTI
Karyopharm Therapeutics Inc. Healthcare
CBP

Christopher Brett Primiano

Chief Business Officer
Newton, MA

Track Institutional and Insider Activities on AURA

Follow Aura Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AURA shares.

Notify only if

Insider Trading

Get notified when an Aura Biosciences, Inc. insider buys or sells AURA shares.

Notify only if

News

Receive news related to Aura Biosciences, Inc.

Track Activities on AURA